Feb 4 2010
CardiacAssist Inc. announced today that Penrose-St. Francis
Health Systems, Colorado Springs, Colo., has adopted the
company’s TandemHeart®
System.
“We pride ourselves in offering our patients innovative cardiovascular
treatments that are not widely available”
Penrose-St. Francis Health Systems is in select company: TandemHeart
is now being used in nearly 90% of the “Best U.S. Heart & Heart
Surgery Hospitals” as ranked by U.S. News & World Report—with
nearly 1,900 TandemHeart procedures performed to date at 150 hospitals
across the U.S.
“We pride ourselves in offering our patients innovative cardiovascular
treatments that are not widely available,” said John R. Mehall, MD, Director
of Cardiothoracic Surgery at Penrose St. Francis Health Systems.
“Therefore we are very proud to be the first cardiac center in southern
Colorado to offer this important new life-saving technology to our
cardiac patients.”
FDA-cleared TandemHeart can be placed rapidly by both
interventional cardiologists in a cath lab and by cardiac
surgeons in an operating room to provide short-term circulatory support
to patients requiring additional cardiac assistance. The device provides
effective and reliable temporary circulatory support for critically ill
patients. Hemodynamic support includes a high net blood-flow rate of up
to five liters per minute in the catheterization lab or up to eight
liters per minute in the OR—more than twice the amount of other
available technologies—and is fully reimbursed by Medicare under
existing DRG codes.
“TandemHeart establishes a whole new paradigm for treating cardiac
patients quickly and aggressively,” said Michael Garippa, CEO and
President of CardiacAssist. “Many great hospitals such as Penrose-St.
Francis Health Systems are becoming aware of the significant benefits of
TandemHeart for their cardiac patients, which is why we believe more
passionately than ever that TandemHeart is destined to become standard
of care in extracorporeal circulatory support.”
SOURCE CardiacAssist Inc.